[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fYg6y9lXc8mOu7UmmeWa-u0KdOUWdgkSE2K8FLAzd6aM":8,"$f71U74Zs0Y3r_aqCaE7uuqePJMMRrS2R84rFHeoSr6_c":55,"$fM32BQlqFPvcVHAx3hvX6Zipfm4IL2uolYklLQz_iQeM":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65186,862794,[],"https://cdn.yishi-tong.com/console/store-1/Si4P_fC5H_NUK1-yWqxbthvHo_drnUm_.jpg","周瀚","安丘市人民医院","普外科","主治医师",425,0,"乳腺癌早期药物使用指南：全面了解吡咯替尼与卡培他滨的用药细节","","https://ystcdn.venuertc.com/venue/AI/7a97e6ef-de50-4e8c-8e88-e219e9423481.jpg","\u003Cdiv class=\"medicine-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"medicine-guide-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌早期药物使用指南：全面了解吡咯替尼与卡培他滨的用药细节\u003C/h1>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section1\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg1\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1. 说到吡咯替尼和卡培他滨，这些用药细节你必须知道\u003C/h2>\n      \u003Cdiv class=\"medicine-guide-intro\">\n        \u003Cp>\n          很多人对吡咯替尼和卡培他滨这两个名字都有点陌生，其实它们今属靶向与化疗用药的常见成员，被用于乳腺癌早期治疗组合中。比起传统的输液化疗，吡咯替尼是一款口服药物，卡培他滨同样也是片剂，只需在家按要求服用，极大简化了治疗流程。当然，想确保疗效和安全，正确的用法、服用时间、不良反应预防，每一个环节都不能忽略。接下来帮大家详细梳理7个关键用药细节，实打实解决日常用药的各种困惑。\n        \u003C/p>\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section2\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg2\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2. 剂型、成分、作用机制：从基础信息了解两款药物\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">吡咯替尼\u003C/span>（Pyrotinib）：片剂，常见规格为80mg和160mg。属于小分子酪氨酸激酶抑制剂，可阻断HER1、HER2及HER4受体信号，抑制肿瘤细胞增殖。\u003Cspan class=\"medicine-guide-emoji\">💊\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">卡培他滨\u003C/span>（Capecitabine）：同为片剂，常见规格为0.5g。属于口服化疗药物，进入体内后转化为活性成分氟尿嘧啶，阻断癌细胞DNA合成过程，从而导致细胞死亡。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>吡咯替尼和卡培他滨的联用，目的是通过双重干预癌细胞的生长途径，提高靶向抑制效果。\u003C/p>\n      \u003Cp class=\"medicine-guide-data\">\n        \u003Cspan>数据参考：\u003C/span>相关临床研究中，HER2阳性乳腺癌患者采用吡咯替尼联合方案的总有效率达到约88%（Wu J, et al., 2021, SABCS）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section3\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg3\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3. 正确服药时间 & 服用方式：别让药效打折\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">吡咯替尼\u003C/span>建议每日同一时间口服，400mg/次，一天一次，最好餐后30分钟内足量清水送服。为保证吸收平稳，避免空腹服用。周期为每21天一疗程。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">卡培他滨\u003C/span>通常总剂量按体表面积计算，分早晚两次餐后30分钟服用，充分饮水吞服。每次服药应间隔约12小时，并尽量同一时间点，避免随意调整时间。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"medicine-guide-correct\">\n        正确做法：两种药都不能掰碎或嚼服，整片吞咽，配足量清水。服药时间建议设定闹钟或者贴醒目便利贴，有助于长期坚持。\n      \u003C/p>\n      \u003Cp>\n        ❗ 偶有患者因漏服影响疗效。\u003Cbr>\n        案例：“有位患者因为忘记按时服用吡咯替尼，出现了药效波动，经提醒后制定服药计划表，用药效果维持良好。”\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section4\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg4\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4. 服药剂量规范，不自行增减\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          吡咯替尼推荐固定剂量，用于联合治疗时400mg/天，不建议自行增减。如果发生严重不良反应，请及时联系医生，有明确降阶梯或停药指征。\n        \u003C/li>\n        \u003Cli>\n          卡培他滨按体重/体表面积计算分两次，每12小时一次。需要严格根据医生处方调整，切勿自行更换剂量。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        推荐：服药时记录在健康手册，每次复诊前带着药盒或照片，方便医生查对用药过程。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"medicine-guide-highlight\">特别提醒：\u003C/span>\u003Cbr>\n        老年人和肝肾功能不全者，常需根据具体情况调整剂量，请严格依医嘱操作。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section5\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg5\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5. 药物相互作用，哪些药品需要特别小心？\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">吡咯替尼\u003C/span> 可能与CYP3A4酶诱导剂（如利福平、苯巴比妥）、CYP3A4抑制剂（如酮康唑）、及部分中草药发生相互作用，可能影响药物血药浓度。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">卡培他滨\u003C/span> 不宜与华法林（抗凝药）、苯妥英等同时使用，两者合用有导致药物反应增强的风险。\n        \u003C/li>\n        \u003Cli>\n          抗酸药、某些感冒药或止泻药均需询问药师再决定是否可以同时服用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"medicine-guide-correct\">\n        正确做法：服药前如在用其他处方药、非处方药及保健品，应主动告知医生和药师，帮你规避潜在风险。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"medicine-guide-highlight\">案例分享：\u003C/span>“临床上曾有患者因合用某些抗癫痫药导致卡培他滨药效不稳定，后改用无需相互作用的替代药物，安全性获得提升。”\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"medicine-guide-section medicine-guide-section6\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg6\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6. 常见不良反应：早发现早对策\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">吡咯替尼\u003C/span>最常见的是腹泻（发生率高达约44-50%\u003Csup>[Wu J, et al., 2021]\u003C/sup>）、口腔炎、恶心、呕吐。腹泻严重时可能需要暂停用药或降剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"medicine-guide-highlight\">卡培他滨\u003C/span>常见手足综合征（手脚疼痛、发红、脱皮）、腹泻、口腔炎、恶心、白细胞减少。如果出现严重不适，请立即就医。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        药师建议：如服用吡咯替尼期间出现腹泻，可以按医嘱提前备好洛哌丁胺，遵医嘱分次服用，预防升级。卡培他滨致手足综合征时需注意皮肤护理，保持双手双脚干燥，出现水泡及时就诊。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"medicine-guide-highlight\">案例参考：\u003C/span>“一位患者服用吡咯替尼后连续腹泻，经药师指导预防性使用洛哌丁胺并调整饮食后，症状明显改善，用药得以顺利进行。”\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"medicine-guide-highlight\">需要注意：\u003C/span>青霉素过敏等药物过敏史患者，首次服用新药时应密切关注自身状态，万一皮疹、气喘、呼吸困难须立即就近就医。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"medicine-guide-section medicine-guide-section7\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg7\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7. 常见操作困惑：漏服、过量怎么处理？\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          漏服吡咯替尼或卡培他滨时，若间隔时间接近下一次，直接跳过，不可一次两倍补服。\u003Cbr>\n          如果刚漏服不久，可立即补服。切记不能随意增加单次量。\n        \u003C/li>\n        \u003Cli>\n          误服过量：应第一时间联系医生或前往医院急诊，说明药物及服用剂量，不要擅自处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：日常服药前多备少量药片，用小药盒按分装提醒，出行前预留足够药量，避免中断。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section8\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg8\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8. 储存要求与药品管理，别让药失效\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          吡咯替尼、卡培他滨应密封避光，置于干燥阴凉处（一般要求20-25℃），避免受潮。勿放冰箱或高温暴晒处，远离儿童宠物。\n        \u003C/li>\n        \u003Cli>\n          切忌与洗涤剂、饮料等混放。药片若出现变色、受潮、破损，建议立即停用处理。\n        \u003C/li>\n        \u003Cli>\n          药品超出有效期不可再服。过期药应投入专用回收站，不随生活垃圾丢弃。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        日常建议：用药盒贴条注明药名、开封日期、有效期，做到心中有数，实行“先进先用”原则。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section9\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg9\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9. 服药期间的自我监测和风险防控\u003C/h2>\n      \u003Cul class=\"medicine-guide-list\">\n        \u003Cli>\n          每个周期留意大便形态、口腔状况、皮肤变化，发现异常（如腹泻、溃疡、明显出血、严重脱皮、皮疹）时，先暂停用药，及时就医复查。\n        \u003C/li>\n        \u003Cli>\n          如遇与日常其他药物冲突，明确由医师或药师协助调整顺序和方案，不擅自改药。\n        \u003C/li>\n        \u003Cli>\n          营养均衡、注意饮水充足，忌油腻辛辣。用药期间保持规律作息，有助提升耐受性。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        有家人协助监督服药更易执行。服药时的困惑，及时用好“药师—医生—医院药物咨询平台”等正规渠道。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"medicine-guide-section medicine-guide-section10\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg10\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10. 重点总结：安全、有效用药，离不开科学细节\u003C/h2>\n      \u003Cdiv class=\"medicine-guide-conclusion\">\n        \u003Cul>\n          \u003Cli>\n            吡咯替尼、卡培他滨属于专业口服乳腺癌治疗药物，需严格按医嘱定量、定时、足量清水送服，不能随意增减剂量或自行停药。\n          \u003C/li>\n          \u003Cli>\n            腹泻、手足综合征等不良反应风险较高，可提前备好对症药物。首次服药和剂量调整期间应密切监测身体反应。\n          \u003C/li>\n          \u003Cli>\n            药物保存、用药漏服及过量处理都需有常备预案，遇特殊情况第一时间联系医生，不能冒险。\n          \u003C/li>\n        \u003C/ul>\n        \u003Cp>\n          只有了解每个关键用药细节，从准备到储存、从服药到自我监测，才能最大程度保护自己和家人。遇到拿不准的情况，切勿拖延，立即寻求专业帮助——用药安全永远第一位！\n        \u003C/p>\n        \u003Cp>\n          \u003Cspan class=\"medicine-guide-emoji\">📝\u003C/span>\n          未来有新的药物信息请持续关注专业药师平台，按最新权威指南落实用药。\n        \u003C/p>\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n    \u003Csection class=\"medicine-guide-section medicine-guide-section11\">\n    \u003Cdiv class=\"medicine-guide-section-bg medicine-guide-bg11\">\n      \u003Ch2 class=\"medicine-guide-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献（部分英文原文）\u003C/h2>\n      \u003Col class=\"medicine-guide-reference-list\">\n        \u003Cli>Wu, J. et al. (2021). Safety and efficacy of pyrotinib plus trastuzumab and docetaxel in early and locally advanced HER2-positive breast cancer (PHEDRA). San Antonio Breast Cancer Symposium (SABCS), Abstract PD8-08.\u003C/li>\n        \u003Cli>Liu, Z. et al. (2020). Efficacy and Safety of Pyrotinib Plus Capecitabine in Patients With HER2-Positive Metastatic Breast Cancer: A Multicenter, Open-Label, Phase II Study. \u003Ci>Journal of Clinical Oncology\u003C/i>, 38(22), 2756-2766. https://doi.org/10.1200/JCO.19.02709\u003C/li>\n        \u003Cli>Nami, B., & Wang, Z. (2018). HER2 in breast cancer stemness: A negative feedback loop towards trastuzumab resistance. \u003Ci>Cancers (Basel)\u003C/i>, 10(10), 342. https://doi.org/10.3390/cancers10100342\u003C/li>\n        \u003Cli>Gianni, L. et al. (2016). 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): A multicentre, open-label, phase 2 randomised trial. \u003Ci>Lancet Oncology\u003C/i>, 17(6), 791-800.\u003C/li>\n        \u003Cli>中国临床肿瘤学会乳腺癌专委会共识专家组. (2020). 乳腺癌靶向人表皮生长因子受体2酪氨酸激酶抑制剂不良反应管理共识. \u003Ci>中华肿瘤杂志\u003C/i>, 42(10), 798-806. (Chinese National Consensus)\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.medicine-guide-container {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  max-width: 860px;\n  margin: 40px auto 40px auto;\n  background: #f8f9fa;\n  border-radius: 16px;\n  padding: 30px 32px 24px 32px;\n  box-shadow: 0 4px 24px rgba(46, 91, 255, 0.09);\n}\n.medicine-guide-main-title {\n  text-align: center;\n  font-size: 2.2em;\n  letter-spacing: 1px;\n  margin-bottom: 28px;\n  color: #004a59;\n  font-weight: 800;\n}\n.medicine-guide-section {\n  margin-bottom: 32px;\n  border-radius: 10px;\n  overflow: hidden;\n  box-shadow: 0 4px 14px rgba(0, 90, 128, 0.04);\n}\n.medicine-guide-section-bg {\n  padding: 34px 24px 24px 24px;\n  background-repeat: repeat;\n}\n.medicine-guide-section-title {\n  font-size: 1.36em;\n  font-weight: 600;\n  color: #0e4b68;\n  margin-bottom: 16px;\n  letter-spacing: 1px;\n}\n.medicine-guide-intro {\n  font-size: 1.02em;\n  line-height: 1.7;\n  color: #325A5C;\n  margin-bottom: 10px;\n}\n.medicine-guide-list {\n  margin-left: 0;\n  padding-left: 16px;\n  font-size: 1.01em;\n  line-height: 1.70;\n  color: #133742;\n  margin-bottom: 10px;\n}\n\n.medicine-guide-list li {\n  margin-bottom: 6px;\n  position: relative;\n  padding-left: 16px;\n}\n.medicine-guide-list li::before {\n  content: \"●\";\n  color: #85b4c2;\n  display: inline-block;\n  position: absolute;\n  left: 0;\n  font-size: 1em;\n  top: 1px;\n}\n\n.medicine-guide-highlight {\n  color: #186697;\n  font-weight: bold;\n}\n.medicine-guide-correct {\n  background: #ddf4ff;\n  padding: 10px 12px;\n  border-radius: 5px;\n  margin: 10px 0 14px 0;\n  color: #014868;\n  font-size: 1em;\n  border-left: 5px solid #6ac0ec;\n}\n.medicine-guide-section1 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #dceffc 0%, #f9fbff 100%);\n}\n.medicine-guide-section2 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #e8f9e9 0%, #f6fbf7 100%);\n}\n.medicine-guide-section3 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #f7e7ff 0%, #f8fbfd 100%);\n}\n.medicine-guide-section4 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #fef4db 0%, #fff7ee 100%);\n}\n.medicine-guide-section5 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #eaf8fe 0%, #fafdfe 100%);\n}\n.medicine-guide-section6 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #ffe9e9 0%, #fffdfd 100%);\n}\n.medicine-guide-section7 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #dbf9fc 0%, #f9fdff 100%);\n}\n.medicine-guide-section8 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #fdffef 0%, #fbfcf7 100%);\n}\n.medicine-guide-section9 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #eafcf7 0%, #f9fcfb 100%);\n}\n.medicine-guide-section10 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #eafdff 0%, #f8faff 100%);\n}\n.medicine-guide-section11 .medicine-guide-section-bg {\n  background: linear-gradient(90deg, #f5f8fa 0%, #f8fbfd 100%);\n}\n.medicine-guide-data {\n  font-size: 0.98em;\n  color: #245B61;\n  background: #f6fcff;\n  border-left: 4px solid #83c8e0;\n  padding: 8px 10px;\n  margin-top: 10px;\n  margin-bottom: 8px;\n  border-radius: 4px;\n}\n.medicine-guide-emoji {\n  font-size: 1.16em;\n  vertical-align: -2px;\n  margin-left: 4px;\n}\n.medicine-guide-conclusion {\n  background: #f5f8ff;\n  padding: 14px 18px;\n  border-radius: 8px;\n  border-left: 5px solid #469ecc;\n  font-size: 1.08em;\n  line-height: 1.72;\n}\n.medicine-guide-conclusion ul {\n  list-style-type: disc;\n  padding-left: 20px;\n  margin-bottom: 10px;\n  color: #0c5b6b;\n}\n.medicine-guide-reference-list {\n  margin-left: 0;\n  padding-left: 20px;\n  font-size: .98em;\n  line-height: 1.7;\n  color: #56616f;\n}\n.medicine-guide-reference-list li {\n  margin-bottom: 7px;\n}\n@media screen and (max-width: 600px) {\n  .medicine-guide-container {\n    padding: 14px 4% 16px 4%;\n    max-width: 100%;\n    font-size: 1em;\n  }\n  .medicine-guide-section-bg {\n    padding: 20px 4% 15px 6%;\n  }\n  .medicine-guide-main-title {\n    font-size: 1.25em;\n    line-height: 1.35em;\n    padding-bottom: 5px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"medicine-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"medicine-guide-main-title\" s",506,"2025-08-29 10:29:30","乳腺癌, 吡咯替尼, 卡培他滨, 用药指南, 药物相互作用","本指南深入剖析吡咯替尼和卡培他滨的用药细节，助力乳腺癌患者了解治疗方案与注意事项，确保安全有效的使用药物。","2025-09-08 13:42:16",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]